FLEMING MEDICAL LIMITED

Company Registration Number:
08117103 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

FLEMING MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

FLEMING MEDICAL LIMITED

Balance sheet

As at 31 December 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 14,251 19,461
Investments:   0 0
Total fixed assets: 14,251 19,461
Current assets
Stocks: 0 0
Debtors: 4 260,266 261,744
Cash at bank and in hand: 850,025 416,356
Investments:   0 0
Total current assets: 1,110,291 678,100
Creditors: amounts falling due within one year:   (827,465) (451,846)
Net current assets (liabilities): 282,826 226,254
Total assets less current liabilities: 297,077 245,715
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 297,077 245,715
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 296,977 245,615
Shareholders funds: 297,077 245,715

The notes form part of these financial statements

FLEMING MEDICAL LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 16 April 2025
and signed on behalf of the board by:

Name: Mark Fleming
Status: Director

The notes form part of these financial statements

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 9 7

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible Assets

Total
Cost £
At 01 January 2024 26,048
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2024 26,048
Depreciation
At 01 January 2024 6,587
Charge for year 5,210
On disposals 0
Other adjustments 0
At 31 December 2024 11,797
Net book value
At 31 December 2024 14,251
At 31 December 2023 19,461

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Debtors

2024 2023
££
Debtors due after more than one year: 260,266 261,744

FLEMING MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Related party transactions

Name of the related party: Fleming Medical Limited (irish)
Relationship:
Common Shareholders
Description of the Transaction: Supply of Goods
£
Balance at 01 January 2024 349,698
Balance at 31 December 2024 667,303